Published TCIMAIL newest issue No.201
Maximum quantity allowed is 999
CAS RN: 144060-53-7 | Product Number: F0847
Febuxostat
Purity: >97.0%(T)(HPLC)
- 2-(3-Cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic Acid
* Stock available in Belgium: Shipment on the same day
* Stock available in Japan: Please check the Shipping Simulation for estimated shipments. (excludes regulated items and dry ice shipments)
| Product Number | F0847 |
Purity / Analysis Method
|
>97.0%(T)(HPLC) |
| Molecular Formula / Molecular Weight | C__1__6H__1__6N__2O__3S = 316.38 |
| Physical State (20 deg.C) | Solid |
Storage Temperature
|
Room Temperature (Recommended in a cool and dark place, <15°C) |
Packaging and Container
|
1G-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 144060-53-7 |
| Reaxys Registry Number | 8005333 |
| PubChem Substance ID | 172089002 |
| Merck Index (14) | 3948 |
| MDL Number | MFCD00871598 |
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 97.0 area% |
| Purity(Neutralization titration) | min. 97.0 % |
| Melting point | 207.0 to 211.0 °C |
| NMR | confirm to structure |
| Melting Point | 209 °C |
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 + H312 + H332 : Harmful if swallowed, in contact with skin or if inhaled. H315 : Causes skin irritation. H319 : Causes serious eye irritation. |
| Precautionary Statements | P261 : Avoid breathing dust. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection/ hearing protection. P337 + P313 : If eye irritation persists: Get medical advice/ attention. P302 + P352 + P312 : IF ON SKIN: Wash with plenty of water. Call a POISON CENTER/doctor if you feel unwell. P304 + P340 + P312 : IF INHALED: Remove person to fresh air and keep comfortable for breathing. Call a POISON CENTER/doctor if you feel unwell. |
| RTECS# | XJ3675310 |
| HS Number | 2934100090 |
References
- An Extremely Potent Inhibitor of Xanthine Oxidoreductase
- Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase
- Hypouricemic effect of the novel xanthine oxidase inhibitor, TEI-6720, in rodents
- Effects of febuxostat on metabolic and renal alterations in rats with fructose-induced metabolic syndrome
References
- An extremely potent inhibitor of xanthine oxidoreductase. Crystal structure of the enzyme-inhibitor complex and mechanism of inhibition
- Selectivity of febuxostat, a novel non-purine inhibitor of xanthine oxidase/xanthine dehydrogenase
- Febuxostat: a selective xanthine oxidase inhibitor for the treatment of hyperuricemia and gout (a review)
- Quantification of uric acid, xanthine and hypoxanthine in human serum by HPLC for pharmacodynamic studies
- Development and Validation of a Stability-Indicating RP-HPLC Method for the Determination of Febuxostat (a Xanthine Oxidase Inhibitor)
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
The requested SDS is not available.
Specifications
The requested specifications are not available.
Please Contact Us for more information.
The requested specifications are not available.
C of A & Other Certificates
Please check that the lot number you have entered is correct. It is 4-5 alphanumeric characters before the hyphen. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
If your information is correct and you are still not able to view the requested certificates, Please Contact Us for more information.
Please check that the lot number you have entered is correct. It is 7 alphanumeric characters. In particular, please check O (letter) or 0 (number) and I (letter) or 1 (number).
Sample C of A
A sample C of A for this product is not available at this time.
Analytical Charts
The requested analytical chart is not available. Sorry for the inconvenience.